Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Nutrigenomics Market: By Product Type, Sample Type, By Application, By End User, and Geography
Nutrigenomics Market size was valued at US$ 463.1 million in 2023 and is poised to grow at a CAGR of 17.3% from 2024 to 2030. The rising incidence of obesity is one of the key market driver projected to boost the market growth during the forecast period. The significance of nutritious food among preventative measures for malnutrition, multiple cardiovascular diseases, obesity, and related disorders is also anticipated to drive the growth of the nutrigenomics industry. Globally, the increasing cancer incidence rates are predicted to drive market development. A better understanding of the genetic component of both wellness and illness, among effective therapeutic interventions to help with disease diagnosis, are two additional benefits of nutrigenomics.
Furthermore, understanding the molecular interactions between nutrients and the genome is the main goal of nutrigenomics, which aims to know how different nutrients and dietary patterns can impact human health. It is projected that nutrigenomics would strongly care for the newly developed therapeutic techniques. Nutrigenomics services have developed as a result of growth in the genomics research. Thus, it is predicted that the market will be driven by the rising application of nutrition within the target demographic and several advantages, such as a focus on illness prevention and reducing the indications of aging which subsequently aid in the expansion of the market. Moreover, the rapid acceptance of genomics and personalized medicine, the rising prevalence of lifestyle diseases like obesity and diabetes, rising awareness of preventative healthcare, and different beneficial pricing strategies employed by market players are some of the favourable factors likely to drive the growth of the market.
Study Period
2024 - 2030Base Year
2023CAGR
17.3%Largest Market
North AmericaFastest Growing Market
N/A
The rapid advancement of genomic sequencing, omics technology, and the ability to manage the disease as early as possible has executed strong attention on preventive healthcare. In addition, the preventive medical nutrition emphasizes erasing the probability of the origin of the disease.
Moreover, the specific field of Metabonomics has appeared to deal with the study of the estimation of metabolic responses based on nutrient deficiency, which is an approach to characterize the metabolic phenotype of individuals and expect their respective interactions with the environment, gut microbiota, and behaviour. It also has a substantial role in personalized nutrition management and disease prevention. Thus, the increasing demand for preventive medicine through personalized nutrition drives the nutrigenomics market growth.
Report Benchmarks |
Details |
Report Study Period |
2024 - 2030 |
Market Size in 2023 |
US$ 463.1 million |
Market CAGR |
17.3% |
By Product Type |
|
By Sample Type |
|
By Application |
|
By End Users |
|
Download Free Sample Report
The nutrigenomics market size was valued at US$ 463.1 million in 2023 and is set to grow at a significant CAGR of 17.3% from 2024-2030.
The demand for nutrigenomics is expected to rise due to the prevalence of cardiovascular diseases and obesity among the growing population.
North America is expected to provide more business opportunities for the global nutrigenomics testing market in the future
The leading players in the nutrigenomics market are Vitagene, Mapmygenome, Gini Health, geneOmbio, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., and Xcode Life.
Historic years considered for the market study are 2019 to 2022, 2023 is considered as the base year for market estimation and the forecast presented from 2024 to 2030.
1. Executive Summary |
2. Global Nutrigenomics Market Introduction |
2.1. Global Nutrigenomics Market Taxonomy |
2.2. Global Nutrigenomics Market Definitions |
2.2.1. Product Type |
2.2.2. Sample Type |
2.2.3. Application |
3. Global Nutrigenomics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Nutrigenomics Market Dynamic Factors - Impact Analysis |
3.6. Global Nutrigenomics Market Competition Landscape |
4. Global Nutrigenomics Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Nutrigenomics Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Reagents |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Kits |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Services |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Nutrigenomics Market Forecast, By Sample Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. Saliva |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Buccal Swab |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Blood |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Nutrigenomics Market, By Application, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1. Diabetes |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Obesity |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Gastrointestinal |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Woman's Health |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Neurological |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Others |
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
8. Global Nutrigenomics Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application and Region, 2024 - 2030 |
9. North America Nutrigenomics MarketAnalysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Reagents |
9.1.2. Kits |
9.1.3. Services |
9.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Saliva |
9.2.2. Buccal Swab |
9.2.3. Blood |
9.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Diabetes |
9.3.2. Obesity |
9.3.3. Gastrointestinal |
9.3.4. Woman's Health |
9.3.5. Neurological |
9.3.6. Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. USA |
9.4.2. Canada |
9.5. North America Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application, and Country, 2024 - 2030 |
9.6. North America Nutrigenomics Market Dynamics Trends |
10. Europe Nutrigenomics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Reagents |
10.1.2. Kits |
10.1.3. Services |
10.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Saliva |
10.2.2. Buccal Swab |
10.2.3. Blood |
10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Diabetes |
10.3.2. Obesity |
10.3.3. Gastrointestinal |
10.3.4. Woman's Health |
10.3.5. Neurological |
10.3.6. Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Rest of Europe |
10.5. Europe Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application, and Country, 2024 - 2030 |
10.6. Europe Nutrigenomics Market Dynamics Trends |
11. Asia-Pacific Nutrigenomics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Reagents |
11.1.2. Kits |
11.1.3. Services |
11.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Saliva |
11.2.2. Buccal Swab |
11.2.3. Blood |
11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Diabetes |
11.3.2. Obesity |
11.3.3. Gastrointestinal |
11.3.4. Woman's Health |
11.3.5. Neurological |
11.3.6. Others |
11.4. Country Analysis2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Japan |
11.4.2. China |
11.4.3. India |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application, and Country, 2024 - 2030 |
11.6. Asia-Pacific Nutrigenomics Market Dynamics Trends |
12. Latin America Nutrigenomics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Reagents |
12.1.2. Kits |
12.1.3. Services |
12.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Saliva |
12.2.2. Buccal Swab |
12.2.3. Blood |
12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Diabetes |
12.3.2. Obesity |
12.3.3. Gastrointestinal |
12.3.4. Woman's Health |
12.3.5. Neurological |
12.3.6. Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Argentina |
12.4.4. Rest of Latin America |
12.5. Latin America Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application, and Country, 2024 - 2030 |
12.6. Latin America Nutrigenomics Market Dynamics Trends |
13. Middle East and Africa Nutrigenomics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
13.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Reagents |
13.1.2. Kits |
13.1.3. Services |
13.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Saliva |
13.2.2. Buccal Swab |
13.2.3. Blood |
13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Diabetes |
13.3.2. Obesity |
13.3.3. Gastrointestinal |
13.3.4. Woman's Health |
13.3.5. Neurological |
13.3.6. Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. Israel |
13.4.3. South Africa |
13.4.4. Rest of MEA |
13.5. MEA Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application, and Country, 2024 - 2030 |
13.6. MEA Nutrigenomics Market Dynamics Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Sample Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. WellGen Inc |
14.2.2. Metagenics Inc. |
14.2.3. Genomix Nutrition Inc. |
14.2.4. Nutrigenomix |
14.2.5. NutraGene |
14.2.6. XCODE Life Sciences Pvt. Ltd |
14.2.7. Cura Integrative Medicine |
14.2.8. NutriProCan |
14.2.9. GX Sciences, Inc. |
14.2.10. Vitl |
15. Research Methodology |
16. Key Assumptions and Acronyms |
Key Market Players